₩176.5 bil was spent on atopic dermatitis every year

NHI medical expenditures for atopic dermatitis amount to KRW 176.5 bil a yr...rose 114.4% in 5 years

34% of the expenses were spent by patients in their 20s, 19% by those in their 30s, and 12% by those in their 20s

The National Health Insurance medical expenditures spent by patients with atopic dermatitis have risen every year to record KRW 176.5 billion last year.

 

This is a 114.4% rise in 5 years.

 

By age group, patients in their 20s accounted for 34.1% of the total expenditures, followed by those in their 30s (18.9%), then those in their 40s (11.8%).

 

The National Health Insurance Service analyzed the NHI treatment data for atopic dermatitis from 2018 to 2022 using NHI data.

 

The number of patients who received treatment for atopic dermatitis had increased from 92,0487 to 971,116 (5.5%↑), at an average annual increase rate of 1.3%.

 

The number of male patients increased by 0.5% (1982↑) from 438,756 in 2018 to 440,738 in 2022, and female patients increased by 10.1% (48,647↑) from 481,731 in 2018 to 530,378 in 2022.

 

Atopic dermatitis patients by gender (2018-2022)

Looking at the composition of the number of patients treated for atopic dermatitis by age group, the most number of patients treated were 9 years old or younger, accounting for 28% (271,613) of all those treated in 2022 (971,116).

 

Those in their 20s accounted for 16.7% (161,711), followed by teenagers accounting for 15.5% (150,837 people).

 

Among male patients, those under the age of 9 accounted for the highest proportion (32.3%), followed by those in their teens (17.3%), then those in their 20s (16.4%).

 

Among female patients, those under the age of 9 accounted for the highest proportion (24.4%), followed by those in their 20s (16.8%), then those in their teens (14.0%).

 

When looking at the number of patients with atopic dermatitis per 100,000 population by year, the number rose from 1,802 in 2018 to 1,889 in 2022 (4.8%).

 

Health insurance treatment costs for patients with atopic dermatitis increased by 114.4% (94.2 billion won) from 82.3 billion won in 2018 to 176.5 billion won in 2022, with an average annual increase of 21%.

 

NHI expenditures spent to treat atopic dermatitis increased by 114.4% (KRW 94.2 billion) from KRW 82.3 billion in 2018 to KRW 176.5 billion in 2022, at an average annual increase of 21%.

 

As of 2022, when looking at the proportion of NHI medical expenditures spent on patients with atopic dermatitis by age, those in their 20s accounted for the most at 34.1% (KRW 60.2 billion), followed by those in their 30s with 18.9% (KRW 33.3 billion) and those in their 40s with 11.8% (KRW 20.8 billion).

 

By gender, both males and females in their 20s accounted for the most, accounting for 37.2% (KRW 40.3 billion) and 29.1% (KRW 19.9 billion), respectively.